Your browser doesn't support javascript.
loading
Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms.
Kanagal-Shamanna, Rashmi; Hodge, Jennelle C; Tucker, Tracy; Shetty, Shashi; Yenamandra, Ashwini; Dixon-McIver, Amanda; Bryke, Christine; Huxley, Emma; Lennon, Patrick A; Raca, Gordana; Xu, Xinjie; Jeffries, Sally; Quintero-Rivera, Fabiola; Greipp, Patricia T; Slovak, Marilyn L; Iqbal, M Anwar; Fang, Min.
Afiliação
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston TX, USA. Electronic address: rkanagal@mdanderson.org.
  • Hodge JC; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Pediatrics, University of California Los Angeles, Los Angeles, CA, USA; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Tucker T; Department of Pathology and Laboratory Medicine, Cancer Genetics Laboratory, British Columbia Cancer Agency, Vancouver, BC Canada.
  • Shetty S; Department of Pathology, UHCMC, University Hospitals and Case Western Reserve University, Cleveland, OH, USA.
  • Yenamandra A; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Dixon-McIver A; IGENZ, Auckland, New Zealand.
  • Bryke C; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Huxley E; West Midlands Regional Genetics Laboratory, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Lennon PA; PathGroup, Nashville TN, USA.
  • Raca G; Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, CA, USA.
  • Xu X; ARUP Laboratories, University of Utah, Salt Lake City, UT, USA.
  • Jeffries S; West Midlands Regional Genetics Laboratory, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Quintero-Rivera F; Department of Pathology and Laboratory Medicine, UCLA Clinical Genomics Center, University of California Los Angeles, Los Angeles, CA, USA.
  • Greipp PT; Department of Laboratory Medicine and Pathology, Genomics Laboratory, Mayo Clinic, Rochester, MN, USA.
  • Slovak ML; TriCore Reference Laboratories, University of New Mexico, Albuquerque, NM, USA.
  • Iqbal MA; University of Rochester Medical Center, Rochester, NY, USA.
  • Fang M; Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA, USA. Electronic address: mfang@seattlecca.org.
Cancer Genet ; 228-229: 197-217, 2018 12.
Article em En | MEDLINE | ID: mdl-30377088
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Perda de Heterozigosidade / Variações do Número de Cópias de DNA / Transtornos Mieloproliferativos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Genet Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Perda de Heterozigosidade / Variações do Número de Cópias de DNA / Transtornos Mieloproliferativos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Genet Ano de publicação: 2018 Tipo de documento: Article